Sign in
4

Changes in Ownership

Dogwood Therapeutics, Inc. Filed Acc 0001104659-21-003576

Options or other derivatives

  • Chief Executive Officer acquired 21,796 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Duncan Gregory Scott · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-01-11 Grant or award : show line 1 in the form Stock Option (right to buy) +21,796 435,921 D
Loading xslF345X03/tm212264-5_4seq1.xml…